Environmental agents affect skeletal growth and development

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 81, Issue 1, 2007, Pages 41-50

  Holz, Jonathan D ^a   Sheu, Tzong Jen ^a   Drissi, Hicham ^a   Matsuzawa, Mitsuhiro ^b   Zuscik, Michael J ^a   Puzas, J Edward ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; ENVIRONMENTAL CHEMICAL; HEAVY METAL; LEAD; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE;

BONE DEVELOPMENT; BONE GROWTH; CARTILAGE CELL; CHONDROGENESIS; DEVELOPMENTAL DISORDER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HUMAN; ONTOGENY; OSSIFICATION; OSTEOBLAST; POLLUTANT; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE DEVELOPMENT; CHONDROCYTES; CHONDROGENESIS; ENVIRONMENTAL POLLUTANTS; HUMANS; LEAD POISONING; METALS, HEAVY; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOGENESIS; POLYCYCLIC HYDROCARBONS, AROMATIC; RECEPTORS, ARYL HYDROCARBON;

EID: 34250023792     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20087     Document Type: Review

References (81)

1. Abbott BD, Schmid JE, Pitt JA, et al. 1999. Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol Appl Pharmacol 155:62-70.
2. Angle CR, Thomas DJ, Swanson SA. 1990. Lead inhibits the basal and stimulated responses of a rat osteblast-like cell line ROS 17/2.8 to 1,25 dihydroxyviatmin D3 and IGF-1. Toxicol Appl Pharmacol 103:281-287.
3. Aubin JE, Liu F, Malaval L, Gupta AK. 1995. Osteoblast and chondroblast differentiation. Bone 17:77S-83S.
4. Ballock RT, Heydemann A, Wakefield LM, et al. 1993. TGF-beta1 prevents hypertrophy of epiphyseal chondrocytes: Regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 158:414-429.
5. Blumenthal SL, Baker J, Dossett A, Selby DK. 1988. The role of anterior lumbar fusion for internal disc disruption. Spine 13:566-569.
6. Bouxsein ML, Karasik D. 2006. Bone geometry and skeletal fragility. Curr Osteoporos Rep 4:49-56.
7. Brown CW, Orme TJ, Richardson HD. 1986. The rate of pseudarthrosis (surgical nonunion) in patients who are smokers and patients who are nonsmokers: A comparison study. Spine 11:942-943.
8. Buckwalter JA, Mankin HJ. 1997. Articular cartilage. J Bone Joint Surg 79A:600-632.
9. Carey DE, Liu X. 1995. Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J Bone Miner Res 10:401-405.
10. Carmouche JJ, Puzas JE, Zhang X, et al. 2005. Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect 113: 749-755.
11. Christoffersson JO, Ahlgren L, Schutz , et al. 1986. Decrease of skeletal lead levels in man after end of occupational exposure. Arch Environ Health 41:312-318.
12. Crabill MR, Watkins JP, Morris EL, et al. 1994. Lead foreign body arthropathy in a horse. J Am Vet Med Assoc 205:864-866.
13. Deguchi M, Rapoff AJ, Zdeblick TA. 1998. Posterolateral fusion for isthmic spondylolisthesis in adults: Analysis of fusion rate and clinical results. J Spinal Disord 11:459-464.
14. Dempster DW. 2006. Anatomy and functions of the adult skeleton. In: Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th edition. Ed: Fauvas MJ. American Society for Bone and Mineral Research. Washington, D.C. 7-11.
15. Dillman RO, Crumb CK, Lidsky MJ. 1979. Lead poisoning from a gunshot wound. Report of a case and review of the literature. Am J Med 66:509-514.
16. Farber JM, Rafii M, Schwartz D. 1994. Lead arthropathy and elevated serum levels of lead after a gunshot wound of the shoulder. AJR Am J Roentgenol 162:385-386.
17. Ferguson CM, Schwarz EM, Reynolds PR, et al. 2000. Smad 2 and 3 mediate transforming growth factor-B1-induced inhibition of chondrocyte maturation. Endocrine 141:4728-4735.
18. Fernandez-Salguero P, Pineau T, Hilbert DM, et al. 1995. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722-726.
19. Fernandez-Salguero PM, Ward JM, Sundberg JP, Gonzalez FJ. 1997. Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol 34:605-614.
20. Gerhardsson L, Dahlin L, Knebel R, Schutz A. 2002. Blood lead concentration after a shotgun accident. Environ Health Perspect 110:115-117.
21. Goldman RH, White R, Kales SN, Hu H. 1994. Lead poisoning from mobilization of bone stores during thyrotoxicosis. Am J Ind Med 25:417-424.
22. Grimsley EW, Adams-Mount L. 1994. Occupational lead intoxication: report of four cases. South Med J 87:689-691.
23. Grimsrud CD, Romano PR, D'Souza M, et al. 2001. BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog. J Orthop Res 19:18-25.
24. Hadley MN, Reddy SV. 1997. Smoking and the human vertebral column: A review of the impact of cigarette use on vertebral bone metabolism and spinal fusion. Neurosurgery 41:116-124.
25. Hanley EN Jr, Levy JA. 1989. Surgical treatment of ischemic lumbosacral spondylolisthesis, analysis of variables influencing results. Spine 14:48-50.
26. Harding NR, Lipton Jr, Vigorita VJ, Bryk E. 1999. Experimental lead arthropathy; an animal model. J Trauma 47:951-955.
27. Hayden JM, Mohan S, Baylink DJ. 1995. The insulin-like growth factor system and the coupling of formation to resorption. Bone 17(2 Suppl):93S-98S.
28. Heldin CH, Miyazono K, Ten Dijke P. 1997. TGF-b signaling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
29. Henry EC, Gasiewicz TA. 1993. Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p- dioxin. Biochem J 294(Pt 1):95-101.
30. Hicks D, O'Keefe RJ, Reynolds PR, et al. 1996. Effects of lead on growth plate chondrocyte phenotype. Toxicol Appl Pharmacol 140:164-172.
31. Hilibrand AS, Fye MA, Emery SE, et al. 2001. Impact of smoking on the outcome of anterior cervical arthrodesis with interbody or strut-grafting. J Bone Joint Surg Am 83A:668-673.
32. Ionescu AM, Schwarz EM, Vinson C, et al. 2001. PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J Biol Chem 276:11639-11647.
33. Ishisaki A, Yamato K, Hashimoto S, et al. 1999. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem 274:13637-13642.
34. Jain S, Maltepe E, Lu MM, et al. 1998. Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 73:117-123.
35. Janssens K, ten Dijke P, Janssens S, Van Hul W. 2005. Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774.
36. Klein RF, Wiren KM. 1993. Regulation of osteoblast gene expression by lead. Endocrin 132:2531-2537.
37. Korashy HM, El Kadi AO. 2004. Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology 201:153-172.
38. Lahvis GP, Lindell SL, Thomas RS, et al. 2000. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 97:10442-10447.
39. Landrigan PJ. 1991. Current issues in the epidemiology and toxicology of occupational exposure to lead. Toxicol Ind Health 7:9-14.
40. Lefebvre V, Huang W, Harley V, et al. 1997. Sox-9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1 (II) collagen gene. Mol Cell Biol 17:2336-2346.
41. Leonard MH. 1969. The solution of lead by synovial fluid. Clin Orthop Relat Res 64:255-261.
42. Lian JB, Javed A, Zaidi SK, et al. 2004. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr 14:1-41.
43. Lilis R, Blumberg WE, Fischbein A, et al. 1977. Lead effects among secondary lead smelter workers with blood lead levels below 80 microgram/100 ml. Arch Environ Health 32:256-66.
44. Lilis R, Valciukas JA, Weber JP, Malkin J. 1985. Effects of low-level lead and arsenic exposure on copper smelter workers. Arch Environ Health 40:38-47.
45. Lin X, Liang M, Feng XH. 2000. Smurf2 is a ubiquitin E3 ligase mediating proteosome-dependent degradation of Smad2 in transforming growth factor-b signaling. J Biol Chem 275:36818-36822.
46. Linsenmayer TF, Chen QA, Gibney E, et al. 1991. Collagen types IX and X in the developing chick tibiotarsus: analyses of mRNAs and proteins. Development 111:191-196.
47. Long GJ, Rosen JF, Pounds JG. 1990. Cellular toxicity and metabolism in primary and clonal osteoblastic bone cells. Toxicol Appl Pharmacol 102:346-361.
48. Marcelli C, Yates AJ, Mundy GR. 1990. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 5:1087-1096.
49. Massague J, Hata A, Liu F. 1997. TGF-b signaling through the Smad pathway. Trends Cell Biol 7:187-192.
50. Massague J, Chen Y. 2000. Controlling TGF-b signaling. Genes Dev 14:627-640.
51. Massague J, Blain SW, Lo RS. 2000. TGF-b signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
52. Miyazono K. 2000. TGF-b signaling by Smad proteins. Cytokine Growth Factor Rev 11:15-22.
53. Mooney V, McDermott KL, Song J. 1999. Effects of smoking and maturation on long-term maintenance of lumbar spinal fusion success. J Spinal Disord 12:380-385.
54. Mundlos S, Olsen BR. 1997. Heritable diseases of the skeleton. Part I: molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 11:125-132.
55. Mundy GR. 1996. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin Orthop Relat Res 324:24-28.
56. Nemoto K, Miyata S, Nemoto F, et al. 2000. Gene expression of neurotrophins and their receptors in lead nitrate-induced rat liver hyperplasia. Biochem Biophys Res Commun 275:472-476.
57. O'Keefe RJ, Puzas JE, Brand JS, Rosier RN. 1988. Effects of transforming growth factor-beta on matrix synthesis by chick growth plate chondrocytes. Endocrinology 122:2953-2961.
58. Pearl M, Boxt LM. 1980. Radiographic findings in congenital lead poisoning. Radiology 136:83-84.
59. Peh WC, Reinus WR. 1995. Lead arthropathy: a cause of delayed onset lead poisoning. Skeletal Radiol 24:357-360.
60. Reddick LP. 1971. Plumbism exists today. South Med J 64:446-450.
61. Sailor LZ, Hewick RM, Morris EA. 1996. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J Orthop Res 14:937-945.
62. Sauk JJ, Smith T, Silbergeld EK, et al. 1992. Lead inhibits secretion of osteonectin/SPARC without significantly altering collagen or Hsp47 Production in osteoblast-like ROS 17/2.8 cells. Toxicol Appl Pharmacol 116:240-247.
63. Schane FAX, Gupta RK, Rosen JF. 1992. Lead inhibits 1,25dihydroxyvitamin D3 regulation of calcium metabolism in osteoblastic osteosacoma cells, ROS 17/2.8. Biochem Biophys Acta 1180:187-194.
64. Schmidt JV, Su GH, Reddy JK, et al. 1996. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93:6731-6736.
65. Schmitz MA, Finnegan M, Natarajan R, Champine J. 1999. Effect of smoking on tibial shaft fracture healing. Clin Orthop 365:184-200.
66. Schrenk D. 1998. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo-and xenobiotics. Biochem Pharmacol 55:1155-1162.
67. Schwartz J, Angle CR, Pirkle JL, Pitcher H. 1986. Relationship between childhood blood-lead levels and stature. Pediatrics 77:281-288.
68. Shannon M, Lindy H, Anast C, Graef J. 1988. Recurrent lead poisoning in a child with immobilization osteoporosis. Vet Hum Toxicol 30:586-588.
69. Shukla R, Bornschein RL, Dietrich KN, et al. 1989. Fetal and infant lead exposure: effects on growth in stature. Pediatrics 84:604-612.
70. Shukla R, Dietrich KN, Bornschein RL, et al. 1991. Lead exposure and growth in the early pre-school child: A follow-up report from the Cincinnati lead study. Pediatrics 88:886-892.
71. Silbergeld EK, Schwartz J, Mahaffey K. 1988. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Envir Res 47:79-94.
72. Slavin RE, Swedo J, Cartwright J Jr, et al. 1988. Lead arthritis and lead poisoning following bullet wounds: a clinicopathologic, ultrastructural, and microanalytic study of two cases. Hum Pathol 19:223-235.
73. Switz DM, Elmorshidy ME, Deyerle WM. 1976. Bullets, joints, And lead intoxication. A remarkable and instructive case. Arch Intern Med 136:939-941.
74. Symanski E, Hertz-Picciotto I. 1995. Blood lead levels in relation to menopause, smoking and pregnancy history. Am J Epidemiol 141:1047-1058.
75. Thackaberry EA, Bedrick EJ, Goens MB, et al. 2003. Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicol Sci 76:407-417.
76. Waldron HA. 1979. Target organs. The blood. J Soc Occup Med 29:65-71.
77. Wan M, Cao X. 2005. BMP signaling in skeletal development. Biochem Biophys Res Commun 328:651-657.
78. Windler EC, SMith RB, Bryan WJ, Woods GW. 1978. Lead intoxication and traumatic arthritis of the hip secondary to retained bullet fragments. A case report. J Bone Joint Surg Am 60:254-255.
79. Xu C, Li CY, Kong AN. 2005. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249-268.
80. Zhang Y, Chang C, Gehlin DJ, et al. 2001. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 98:974-979.
81. Zuscik MJ, Pateder DB, Puzas JE, et al. 2002. Lead alters parathyroid hormone-related peptide and transforming growth factor-beta1 effects and AP-1 and NF-κB signaling in chondrocytes. J Orthop Res 20:811-818.